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ATP-citrate lyase promotes axonal transport across
species
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Microtubule (MT)-based transport is an evolutionary conserved process finely tuned by
posttranslational modifications. Among them, α-tubulin acetylation, primarily catalyzed by a
vesicular pool of α-tubulin N-acetyltransferase 1 (Atat1), promotes the recruitment and
processivity of molecular motors along MT tracks. However, the mechanism that controls
Atat1 activity remains poorly understood. Here, we show that ATP-citrate lyase (Acly) is
enriched in vesicles and provide Acetyl-Coenzyme-A (Acetyl-CoA) to Atat1. In addition, we
showed that Acly expression is reduced upon loss of Elongator activity, further connecting
Elongator to Atat1 in a pathway regulating α-tubulin acetylation and MT-dependent transport
in projection neurons, across species. Remarkably, comparable defects occur in fibroblasts
from Familial Dysautonomia (FD) patients bearing an autosomal recessive mutation in the
gene coding for the Elongator subunit ELP1. Our data may thus shine light on the patho-
physiological mechanisms underlying FD.
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Axonal transport is an evolutionary conserved process thatdelivers cargoes to distant subcellular compartments. It issupported by molecular motors (kinesins and dyneins)
running along microtubule (MT) tracks and is particularly
important for projection neurons that send axons to distant
targets. MT-dependent transport contributes to neuronal devel-
opment in growing dendrites and axons via slow axonal transport
of cytoskeletal elements and, later, it sustains survival and
homeostasis of neurons via fast axonal transport of organelles
including mitochondria, lysosomes, and vesicles carrying various
types of proteins (growth factors, synaptic proteins…). Axonal
transport defect is a hallmark of several neurodegenerative dis-
orders, whose disruption affects neuronal function and
survival1–4. This is exemplified by the loss of activity of the
Elongator complex, which is associated with both neurodegen-
eration and axonal transport defects5,6. This molecular complex,
conserved from yeast to human, is composed of two copies of six
distinct protein subunits (Elp1 to Elp6)7. Elp3 is the enzymatic
core of the Elongator and harbors two highly conserved sub-
domains, a tRNA acetyltransferase8 and a S-adenosyl methionine
binding domains9. Elp1 is the scaffolding subunit of the complex,
but disruption of any of the Elongator subunits leads to com-
parable phenotype in eukaryotes, suggesting that all subunits are
essential for the integrity and activity of the complex10,11. Elon-
gator serves molecular functions in distinct subcellular
compartments12 but predominantly accumulates in the cytoplasm
where it promotes the formation of 5-methoxycarbonylmethyl
(mcm5) and 5-carbamoylmethyl (ncm5) on side-chains of wobble
uridines (U34) of selected tRNAs, thereby regulating protein
translation8,13. Convergent observations support a role for
Elongator in intracellular transport in the nervous system as Elp3
is enriched at the presynaptic side of neuromuscular junction
buttons in flies, where its expression is required for synapse
integrity and activity14,15. Elongator subunits are also detected in
protein extracts from purified motile vesicles isolated from the
mouse cerebral cortex16, and they colocalize with the vesicular
markers SV2 and RAB3A in human embryonic stem cells derived
neurons17. In humans, mutation of the gene coding for ELP1,
underlies Familial dysautonomia (FD), a devastating disease that
mostly affects the development and survival of neurons from the
autonomic nervous systems18,19. Moreover, other neurological
disorders are also associated with mutations affecting the
expression or the activity of Elongator5,20–23. Experimental data
on animal models show that interfering with Elongator activity
promotes early developmental and progressive neurodegenerative
defects, including poor axonal transport and maintenance24–27.
At the molecular level, loss of Elongator correlates with poor
acetylation of α-tubulin lysine 40 (K40) in neuronal microtubules
(MT)6,25,28. This post-translational modification (PTM) mod-
ulates axonal transport by facilitating the recruitment of mole-
cular motors to MTs29 and the loading of motile vesicles on
motors6. The acetylation of MTs relies mostly on a vesicular pool
of tubulin acetyltransferase 1 (Atat1)30 that catalyzes the transfer
of acetyl groups from Acetyl-Coenzyme-A (Acetyl-CoA) onto
lysine 40 (K40) of α-tubulin31,32. How loss of Elongator affects
MT acetylation, and whether a functional correlation between
Elongator and Atat1 exists, remains to be explored.
Here, by combining cellular and molecular analyses in mouse
cortical neurons in vitro and fly larva motoneurons (MNs)
in vivo, we show that Elongator is expressed in vesicles and
modulates axonal transport and acetylation of α-tubulin across
species by regulating the stability of ATP-citrate lyase (Acly). This
enzyme is enriched in vesicles and produces acetyl-coA, thereby
providing acetyl groups for Atat1 activity towards MTs. Impor-
tantly, analysis of primary fibroblasts from FD patients show
molecular defects comparable to those observed in mice and fly
projection neurons depleted in Elongator. Therefore, our data
may shine a light on the pathophysiological mechanisms under-
lying FD and other neurological disorders resulting from
impaired Elongator activity.
Results
Elongator and Atat1 cooperate in a common pathway to reg-
ulate the acetylation of α-tubulin and axonal transport. In
order to understand how Elongator controls tubulin acetylation
and MT-based transport, we performed complementary experi-
ments in distinct animal models that lack Elongator activity. We
compared the level of α-tubulin acetylation in cultured cortical
projection neurons (PN) that were isolated from embryonic (E)
day 14.5 WT or Elp3cKO mouse embryos (conditional loss of
Elp3 in cortical progenitors upon breeding Elp3lox/lox33 and
FoxG1:Cre34 transgenic mice). Axon of Elp3 cKO PNs, as well as
cortical extracts from E14.5 Elp3 cKO embryos displayed sig-
nificant reduction of α-tubulin acetylation (Fig. 1a, Supplemen-
tary Fig. 1a). We next assessed axonal transport in PNs that were
cultured in microfluidic devices for 5 days and incubated with
specific dyes to track lysosomes (LysoTracker®) and mitochon-
dria (MitoTracker®) movements by time-lapse videomicroscopy
(Fig. 1b). PNs showed a significant reduction of average and
moving velocities (in anterograde and retrograde directions) of
lysosomes and mitochondria along axons, which correlated with
an increase of their pausing time, as compared to WT PNs
(Supplementary Fig. 1b–h). These results confirmed that loss of
Elongator activity leads to defects of α-tubulin acetylation and
molecular transport in cortical neurons. Since a vesicular pool of
Atat1 promotes acetylation of α-tubulin, thereby controls axonal
transport in cortical PNs30, we postulated that Atat1 and Elon-
gator might contribute to axonal transport via a shared molecular
pathway. To test this hypothesis, we infected cortical PNs from
E14.5 WT and Atat1 KO mice with lentiviruses expressing either
sh-Elp3 or sh-Control (Supplementary Fig. 1i–j), and we cultured
them in microfluidics devices for five days (Fig. 1b). Targeting
Elp3 in WT neurons impaired lysosomes and mitochondria
transport across PN axons. However, we did not observe an
additive effect on MT acetylation or axonal transport kinetics
upon reduction of Elp3 expression in Atat1 KO PNs (which show
reduced acetylation of α-tubulin) (Fig. 1c–e, Supplementary
Fig. 1k–o). Comparable observations were made in vivo in MNs
of Drosophila melanogaster 3rd instar larvae obtained by crossing
UAS:Elp1 or UAS:Elp3 RNAi fly lines with D42:Gal4 (further
called Elp1 KD and Elp3 KD). The knockdown efficiency of the
UAS:Elp1 and UAS:Elp3 in postmitotic neurons was validated in
adult fly heads (Elav:Gal4 driver; Supplementary Fig. 1p–r). We
first confirmed that the level of α-tubulin acetylation was reduced
in Elp1 and Elp3 KD 3rd instar larvae MNs, a defect genetically
rescued by expressing human (h) ELP3 or by co-targeting the
main α-tubulin deacetylase Hdac6 with RNAi (Elp1;Hdac6 KD,
Elp3;Hdac6 KD) (Fig. 1f, Supplementary Fig. 1r). Moreover,
knocking down both Elp3 and Atat1 (Elp3;Atat1 KD) did not
further reduce the α-tubulin acetylation level, as compared to
Elp3 KD alone (Fig. 1f; p= 0.259 and p= 0.775, respectively). In
vivo time-lapse recording of the synaptotagmin-GFP axonal
transport (SYT1-GFP) in MNs of anesthetized fly 3rd instar
larvae (Fig. 1g) correlated with levels of α-tubulin acetylation
(Fig. 1f). We observed a reduction of both the average and
moving velocities of SYT1-GFP vesicles together with an exten-
sion of their pausing time both in Elp1 KD or Elp3 KD larvae
when compared to controls, and with no cumulative defects in
Elp3;Atat1 KD flies (Fig. 1h–j, Supplementary Fig. 1s). Moreover,
knocking down Hdac6 fully rescued the observed axonal trans-
port defects observed in Elp1/3 KD in 3rd instar larvae MNs
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(Elp1;Hdac6 KD, Elp3;Hdac6 KD) (Fig. 1h–j, Supplementary
Fig. 1s).
Interfering with Elongator activity affects codon-biased
translation that can ultimately lead to protein aggregation35,
thereby blocking axonal transport36. However, we did not detect
significant protein aggregation in the axon of either cultured
cortical neurons from Elp3 cKO mice (Supplementary Fig. 1t) or
motoneurons from Elp1 or Elp3 KD 3rd instar larvae in vivo
(Supplementary Fig. 1u), while axonal aggregates formed upon
blocking proteasome activity with MG132 incubation. Altogether,
these results suggest that the axonal transport defects observed in
Elongator deficient neurons unlikely result from a local
accumulation of protein aggregates.
Since impaired axonal transport in fly MNs leads to
locomotion defects1,37, we measured larvae crawling speed and
adult flies climbing index as functional readouts of axonal
transport activity in MNs30,37. These parameters were affected
upon depletion of either Elp1 or Elp3 (Fig. 1k–l), and were likely
resulting from MT acetylation and axonal transport defects, as
they were rescued by the knockdown of Hdac6 (Fig. 1k–l) and no
morphological changes of neuromuscular junction synapses were
observed (Supplementary Fig. 1v).
Elongator shares high amino acid similarity across species
(Supplementary Fig. 1w). Expression of human ELP3 in MNs of
3rd instar larvae of Elp3 KD flies (Elp3 KD+ ELP3) rescued α-
tubulin acetylation (Fig. 1f), axonal transport parameters
(Fig. 1h–j, Supplementary Fig. 1s) and locomotion behavior
defects (Fig. 1k–l), indicating that ELP3, and by extension
Elongator, has a conserved evolutionary role from human to fly in
axonal transport. Moreover, we show that loss of Elongator
activity does not worsen the axonal phenotype of Atat1 KO
neurons, further suggesting that these molecules act in a common
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molecular pathway to modulate MT acetylation and axonal
transport31,32.
Loss of Elongator impairs the production of acetyl-CoA,
thereby interfering with Atat1- mediated MT acetylation. Since
Hdac6 knockdown rescued the axonal transport deficits observed
in neurons lacking Elongator activity (Fig. 1h–j), we tested
whether these defects may arise from a change of expression or
activity of Hdac6 and/or Atat1, the enzymes that control α-
tubulin de/acetylation, respectively38,39. Since no change in
Hdac6 and Atat1 (isoform #3 and #4)30 expression in cortical
extracts from Elp3 cKO and WT littermate newborn mice
(Fig. 2a–c) were observed, we measured the activity of these
enzymes. The deacetylation activity of Hdac6 toward MTs,
assessed in vitro by incubating free acetylated α-tubulin from
bovine brains with cortical extracts from newborn Elp3 cKO or
WT littermate controls38, was comparable between conditions
(Fig. 2d). Atat1 activity was measured by using an in vitro α-
tubulin acetylation assay30. For this assay, pre-polymerized
unacetylated MTs from HeLa cells were incubated with acetyl-
CoA and P0 mouse brain extracts from Elp3 cKO or WT litter-
mate controls (Fig. 2e) to assess the level of acetylation of α-
tubulin. In striking contrast to brain extracts from Atat1 KO
mouse pups, we did not observe any differences in MT acetylation
levels between the cortical extracts from Elp3 cKO and WT mice
upon addition of acetyl-CoA (Fig. 2e). Altogether, these results
suggest that loss of Elongator activity: i) does not impair α-
tubulin acetylation by changing the expression or activity of
Hdac6 or Atat1; ii) may interfere with the metabolic production
of acetyl-CoA. Accordingly, western blotting of E14.5 Elp3cKO
cortical extracts showed that expression of Acyl-coenzyme A
synthetase short-chain family member (Acss2) and Acly, the
enzymes that generate acetyl-CoA40, were significantly reduced,
as compared to control extracts (Fig. 2f–h). Since α-tubulin
acetylation is mainly driven by a vesicular pool of Atat1 in
axons30, we performed sub-fractionation of cortical lysates
(Fig. 2i; T: total, P1: nuclei, S2: cytosolic+ vesicular, P2: mem-
branes, S3: cytosolic, P3: vesicular) from adult WT mice to ana-
lyze the subcellular distribution of Acss2 and Acly. While
Acss2 showed a strict cytosolic distribution (S3), we found that
Acly was strongly enriched together with Elp1 and Elp3 in vesi-
cles (P3) (Fig. 2j–l). These results were supported by immuno-
labeling of cortical neurons that show expression of Acly in some
synapthophysin+ vesicles and Lamp1+ late endosomes in PN
axons (Fig. 2m–n). Moreover, proteomic analysis of cortical
extracts from newborn mice confirmed the vesicular enrichment
of several Elongator subunits, Atat1, Acly, but not Acss2 (Sup-
plementary Fig. 2a). Altogether, these data suggest that α-tubulin
acetylation could be regulated by homeostatic changes in Acly-
dependent acetyl-CoA concentration, as previously observed for
histone acetylation41. Specifically, we postulated that loss of
Elongator could interfere with MT acetylation and axonal
transport via reduction of Acly expression. To test this hypoth-
esis, we performed an in vitro acetyl-CoA production assay
(malate dehydrogenase coupled assay)41, where subcellular frac-
tions of cortical brain extracts from Elp3 cKO and WT littermate
newborns were mixed with Acly substrates (ATP, CoA, and
citrate) (Fig. 2o). The vesicular fraction (P3), which is strongly
enriched into Elongator subunits (Elp1 and Elp3), Atat1 and Acly
(Fig. 2j, Supplementary Fig. 2a), more efficiently produced acetyl-
coA (Fig. 2o–p). While cortical extracts from Elp3 cKO E14.5
mouse embryos showed no change of Acly transcription (Fig. 2q),
we observed a reduction of Acly expression (Fig. 2f–g) together
with a correlative decrease of MTs acetylation (Supplementary
Fig. 1 Reduction of Elongator activity leads to axonal transport defects in mouse and fly. a Immunolabelings and quantification of acetylated α-tubulin
(Ac α-Tub) and total tubulin (Tot Tub) levels in axon of E14.5 WT and Elp3 cKOmice cortical neurons cultured for 5 DIV in microfluidic devices. Scale bar is
10 µm. b Experimental set up to record axonal transport by time-lapse microscopy in E14.5 mice cortical neurons cultured for 5 DIV in microfluidic devices.
c–e Histograms showing axonal transport of lysosomes (LysoTracker®) in WT or Atat1 KO cultured neurons infected with sh-Control or sh-Elp3 to analyze
average (av.) velocity c, moving velocity d, and percentage of pausing time e. f–l Study of Drosophila melanogaster expressing RNAi under a motoneuron
(MN)-specific driver (D42:GAL4); Elp1 KD, Elp3 KD, Atat1; Elp3 KD, Elp3 KD+ human ELP3, Elp1; Hdac6 KD and Elp3;Hdac6 KD. f Immunolabelings and
quantification of acetylated α-tubulin (Ac α-Tub) and total tubulin (Tot Tub) levels in MN axons of 3rd instar larvae, genotype as indicated. Scale bar is
10 µm. g Experimental set up for in vivo time-lapse recording of Synaptotagmin-GFP (Syt1-GFP) axonal transport in 3rd instar larvae motoneurons, to
analyze average (av.) velocity h, moving velocity i, and percentage of pausing time j. k–l Locomotion assays: histograms of the climbing index of adult flies
k and the crawling speed of 3rd instar larvae l. Description of graphical summaries here within are histograms of means ± SEM. Significance was determined
by: a two-sided t test, c, d, e, f, h, i, j, l two-sided Kruskal–Wallis test, and k two-sided one-way analysis of variance (ANOVA). Specifically, [(a)
p= 0.0070, t= 2.812, df = 5; (c) p < 0.0001 and K= 80.47; (d) p < 0.0001, K= 34.30 and p < 0.0001, K= 23.46 for anterograde and retrograde,
respectively, (e) p < 0.0001 and K= 73.34, (f) p < 0.0001, and K= 88.16, (h) p < 0.0001 and K= 223.6, (i) p < 0.0001, K= 110.3, and p < 0.0001,
K= 45.69 for anterograde and retrograde, respectively, (j)p < 0.0001, K= 46.06, (k) p < 0.0001, F= 28.74; (l) p < 0.0001, K= 86.04. In addition, the post
hoc multiple comparisons, to analyze statistical difference of each condition compared to control for (c, d, e, f, h, i, j, l) Dunn’s test, for (k) Dunnet’s test
and are **p < 0.01, ***p < 0.001, and ****p < 0.0001. a Number of axons: WT n= 28; Elp3 cKO n= 28. 3 mice per group. c Number of vesicles: WT+ sh-
Control n= 334; WT+ sh-Elp3 n= 101; Atat1 KO+ sh-Control n= 278; Atat1 KO+ sh-Elp3 n= 79. 3 mice per group. d Number of vesicles: WT+ sh-
Control n= 180 (anterograde), n= 135 (retrograde); WT+ sh-Elp3 n= 66 (anterograde), n= 56; Atat1 KO+ sh-Control n= 129 (anterograde), n= 163
(retrograde); Atat1 KO+ sh-Elp3 n= 58 (anterograde), n= 41 (retrograde). 3 mice per group. e Number of vesicles: WT+ sh-Control n= 333; WT+ sh-
Elp3 n= 104; Atat1 KO+ sh-Control n= 278; Atat1 KO+ sh-Elp3 n= 79. 3 mice per group. f Number of motoneurons: Control n= 32; Elp3 KD n= 20; Elp1
KD n= 18; Elp3;Atat1 KD n= 19; Elp3 KD+ hELP3 n= 14; Elp1;Hdac6 KD n= 36; Elp3;Hdac6 KD n= 15. 5 larvae per group. h Number of vesicles: Control
n= 487; Elp1 KD n= 130; Elp3 KD n= 217; Elp3;Atat1 KD n= 143; Elp3 KD+ ELP3 n= 397; Elp1;Hdac6 KD n= 80; Elp3;Hdac6 KD n= 421. Number of
larvae per group: Control: n= 7; Elp1 KD, Elp3 KD, Elp3;Atat1 KD, Elp3 KD+ ELP3, Elp1;Hdac6 KD, Elp3;Hdac6 KD n= 12. i Number of vesicles: Control
n= 127 (anterograde), n= 159 (retrograde); Elp1 KD n= 118 (anterograde), n= 105 (retrograde); Elp3 KD n= 194 (anterograde), n= 203 (retrograde);
Elp3;Atat1 KD n= 68 (anterograde), n= 81 (retrograde); Elp3 KD+ ELP3 n= 173 (anterograde), n= 247 (retrograde); Elp1;Hdac6 KD n= 50
(anterograde), n= 39 (retrograde); Elp3;Hdac6 KD n= 283 (anterograde), n= 264 (retrograde). Number of larvae per group: Control: n= 7; Elp1 KD, Elp3
KD, Elp3;Atat1 KD, Elp3 KD+ ELP3, Elp1;Hdac6 KD, Elp3;Hdac6 KD n= 12. j Number of vesicles: Control n= 488; Elp1 KD n= 217; Elp3 KD n= 130;
Elp3;Atat1 KD n= 429; Elp3 KD+ ELP3 n= 90; Elp1;Hdac6 KD n= 427; Elp3;Hdac6 KD n= 397. Number of larvae per group: Control: n= 7; Elp1 KD, Elp3
KD, Elp3;Atat1 KD, Elp3 KD+ ELP3, Elp1;Hdac6 KD, Elp3;Hdac6 KD n= 12. k Number of vials: Control n= 15; Elp1 KD n= 5; Elp3 KD n= 6; Elp3;Atat1 KD
n= 7; Elp3 KD+ ELP3 n= 6; Elp1;Hdac6 KD n= 7; Elp3;Hdac6 KD n= 6. Each vial contains 10 adult flies. l Larvae per group: Control n= 21; Elp1 KD n= 15;
Elp3 KD n= 12; Elp3;Atat1 KD n= 18; Elp3 KD+ ELP3 n= 17; Elp1;Hdac6 KD n= 12; Elp3;Hdac6 KD n= 12. Source data are provided with this paper.
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Fig. 1a). Indeed, the analysis of Elp3 cKO and WT newborn
cortices show a robust decrease of Acly protein level in both the
cytosolic and the vesicular fractions (P3, Fig. 2r–t). Comparable
reduction of Acly (but not Atat1) was detected by mass spec-
trometry in the vesiculome of P0 Elp1 KO brains (Supplementary
Fig. 2b–d). Moreover, we detected a reduction of acetyl-CoA level
in cortical extracts from Elp3 cKO mice, as compared to WT
newborn littermates by using LC-MS metabolic analysis (Fig. 2u).
Altogether, these results support a molecular cooperation
occurring at vesicles between the Elongator and Atat1 to drive
MT acetylation via the regulated expression of the enzyme Acly,
which provides acetyl-group donors to Atat1 for catalyzing α-
tubulin acetylation in neurons.
Expression of Acly rescues both acetylation of α-tubulin and
axonal transport defects in flies and mice that lack Elongator
activity. In order to test whether Acly is required for proper axonal
transport, we incubated WT mouse PNs with the Acly inhibitor
hydroxycitric acid (HCA)42. This treatment reduced the level of α-
tubulin acetylation in PNs axons (Fig. 3a). Moreover, incubation of
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HCA reduced average and retrograde moving velocities of lysosomes
along axons, which correlated with an increase of their pausing
times, as compared to vehicle treatment (Fig. 3b–d, Supplementary
Fig. 3a). We next analyzed 3rd instar larvae from Acly KD flies43
whose MNs displayed reduced α-tubulin acetylation (Fig. 3e) toge-
ther with impairment of SYT1-GFP vesicles transport (Fig. 3f–h,
Supplementary Fig. 3b). Knocking down Hdac6 fully rescued the
level of α-tubulin acetylation (Fig. 3e) and the axonal transport
defects observed in Acly KD MNs (Acly KD;Hdac6 KD, Acly;Hdac6
KD) (Fig. 3f–h, Supplementary Fig. 3b). We next postulated that the
impairment of α-tubulin acetylation and axonal transport observed
upon loss of Elongator (Supplementary Fig. 1a–h) may arise from
the reduced expression of Acly in PNs. To test this hypothesis, we
expressed human ACLY (which shares high amino acid homology
with its murine and fly homologues; Supplementary Fig. 3c) in E14.5
control and Elp3cKO PNs that were cultured in microfluidic devices
for 5DIV. We showed that the level of MT acetylation (Fig. 3i) and
the lysosomes and mitochondria transport defects were rescued
upon expression of ACLY (Fig. 3j–l, Supplementary Fig. 3d–g).
Comparable data were obtained with Elp3 KD flies (that also show
reduction of Acly level in the brain, Supplementary Fig. 3h) that
express Acly (UAS:Elp3 RNAi and UAS:Acly, Elp3 KD+Acly) in
MNs during development (3rd instar larvae), where both acetylation
of α-tubulin and axonal transport of SYT1-GFP vesicles were res-
cued to control levels (Fig. 3m–p, Supplementary Fig. 3i). These data
were also correlated with improvement of locomotion activities of
Elp3 KD 3rd instar larvae and adult flies upon Acly expression
(Supplementary Fig. 3j–k).
Altogether, these results suggest that reduction of Acly
expression leads to MTs acetylation and axonal transport defects
in Elongator deficient neurons.
Fibroblasts from Familial Dysautonomia patients show defects
of α-tubulin acetylation and MT-dependent transport. In order
to place our findings in a human pathological context, we ana-
lyzed primary skin fibroblasts from FD patients carrying the
splice site IVS20+ 6T_C variant in ELP144 that expressed barely
detectable amount of ELP1 proteins and low level of ELP3,
resulting from its instability upon nonassembly of the Elongator
complex (Supplementary Fig. 4a)25. We observed a reduction of
acetylation of α-tubulin and MT-dependent transport defects in
FD fibroblasts (Supplementary Fig. 4b–g), which were compar-
able to those observed in neurons from Elongator loss of function
fly and mouse models. This modification was not resulting from
an increased deacetylation activity of HDAC6 toward MTs in
extracts fibroblasts nor an intracellular protein aggregation that
would affect MT-dependent transport in FD fibroblasts (Sup-
plementary Fig. 4h–i). Both the reduction of α-tubulin acetylation
and the defects of MT-dependent transport in cultured FD
fibroblasts were rescued by blocking tubulin deacetylation with
the HDAC6 specific inhibitor, Tubastatin (TBA; 10uM during
30 min) (Supplementary Fig. 4c–g). Similarly to the animal
models, FD fibroblasts express reduced amount of ACLY proteins
(Fig. 4a) and incubation with HCA for 8 h interfered in a dose-
dependent manner with MT acetylation (Fig. 4b), in both control
and FD fibroblasts, in line with the residual expression of ACLY
observed in FD fibroblasts (Fig. 4a). We next showed that over-
expression of ACLY in FD fibroblasts rescued the level of acet-
ylation of α-tubulin (Fig. 4c), as well as the defects of MT-
dependent transport of lysosomes (Fig. 4d–f, Supplementary
Fig. 4j). Altogether, these results demonstrate that reduction of
ACLY in FD fibroblasts leads to MT acetylation and MT-
dependent transport impairments; these molecular defects likely
contribute to the pathological mechanisms underlying FD.
Loss of elongator activity interferes with Acly stability. Elon-
gator is a tRNA modifier and its loss of activity may directly
impair the translation of Acly mRNAs. To address this question,
we performed a polysomal fractionation of cortical extracts of P0
Elp3 cKO and WT littermates to analyze the association of Acly
mRNAs with ribosomes45 and found no differences between
genotypes (Fig. 5a–b). These data were confirmed by labeling
cultured Elp3 cKO an WT PNs with puromycin for 4 min, a
tRNA analogue that incorporates into nascent peptides, causing
their premature chain termination (reviewed in46). We visualized
the de novo synthesis of Acly by combining anti-puromycin with
Fig. 2 Elongator deletion impairs tubulin acetylation and axonal transport via reduction of Acly-dependent acetyl-coA production. a–cWestern blotting
to detect and quantify Hdac6, Elp1, Elp3, Atat1 (isoform #3 and #4)30, and ß-Actin in cortical extracts from newborn WT and Elp3 cKOmice. Histograms of
proportion of Hdac6 b and Atat1 c expression to ß-Actin. d In vitro deacetylation assay of endogenously acetylated bovine brain tubulin incubated for 4 h
with extracts (S3) of cortices isolated from WT, Elp3 cKO, or without tissue extract (control). e In vitro acetylation assay of nonacetylated MTs from HeLa
cells incubated for 2 h with Acetyl-CoA and extracts (P3) of brain cortices isolated from WT, Elp3 cKO or Atat1 KO mice. f–h Immunoblotting to detect
Acss2, Acly, and α-Tub cortical extracts from E14.5 WT and Elp3 cKO embryos and histograms of proportion of Acss2 (g) and Acly (h) expression to α-
Tub. i Experimental pipeline for subcellular fractionation of P0 mouse cortical extracts: T, total; S1, post-nuclear; P1, nuclear; S2, cytosol and vesicles; P2,
large membranes; S3, cytosol; and P3, vesicles. j–l Subcellular fractionation (T, S1, P1, S2, P2, S3, P3) of mouse brain cortex immunoblotted with specific
antibodies to detect Acss2, Acly, Elp1, Elp3, Atat1 (isoform #3 and #4)30, Hdac6, synaptophysin (Syp), α-tubulin (α-Tub), and Histone H3 (HH3).
k–l Histograms of proportion of Acss2 and Acly across subcellular fractions k or expressed as P3/S3 ratio l. Immunolabelings of E14.5 mice cortical
neurons cultured for 5 DIV to detect Acly (purple) and α-tubulin (α-Tub, grey) m; Acly, Synaptophysin-1 (green) and α-Tub (n, top); Acly, Lamp-1-Emerald
(green) and α-Tub (n, bottom). Scale bars are 20 µm (m), 10 µm (n). o–p Analysis of Acly activity by malate dehydrogenase coupled method performed in
WT and Elp3 cKO brain cortex lysates. Histogram of relative Acly activity over assay (o) and of slopes (p) from the linear phase of the reaction. q qRT-PCR
analysis of AclymRNA in cortical brain extracts of Elp3 cKO or WT littermate mice.r–t Immunoblots and quantification of cytosolic (S3, s) and vesicular (P3,
t) fractions of Acly protein from newborn WT and Elp3 cKO mice brain cortices. u LC-MS quantification of Acetyl-CoA levels in WT and Elp3 cKO P0 mice
brain cortex lysates. Description of graphical summaries here within are histograms of means ± SEM. Significance was determined by: b, c, g, h, l, s, t two-
sided t test, q, u two-sided Mann–Whitney test, d, e, p two-sided one-way analysis of variance (ANOVA), and o two-sided two-way ANOVA. Specifically,
[(b) p= 0.8411, t= 0.2093, df = 6; (c) p= 0.7505, t= 0.3248, df = 13; (d) p < 0.0001, F= 21.30; (e) p < 0.0001, F= 85.29; (g) p= 0.0157, t= 0.2.776,
df = 13; (h) p= 0.0013, t= 3.861, df = 17; (l) p= 0.0056, t= 4.638, df = 5; (o) p < 0.0001, FInteraction (294, 882)= 68.07; (p) p < 0.0001, F= 1352; (q)
p= 0.5714, U= 5; (s) p= 0.0145, t= 2.855, df = 12; (t) p= 0.0428, t= 2.470, df = 7; (u) p= 0.0159, U= 0. In addition, the post hoc multiple
comparisons, to analyze statistical difference` of each condition compared to control for (d, e, p) are Holm-Sidak test, and are *p < 0.05, **p < 0.01,
***p < 0.001, and ****p < 0.0001. Number of mice: (b) WT n= 9; Elp3 cKO n= 6; (c) WT n= 4; Elp3 cKO n= 4; (d) Control n= 8; WT n= 4; cKO n= 4;
(e) WT n= 5; Elp3 cKO n= 5; Atat1 KO n= 4; (g) WT n= 7; Elp3 cKO n= 8; (h) WT n= 11; Elp3 cKO n= 8; (l) WT n= 3 (Acly); WT n= 4 (ACSS2);
(o–p) WT n= 4 for 99 time points; (q) WT n= 5; Elp3 cKO n= 3; (s) WT n= 9; Elp3 cKO n= 5; (t) WT n= 4; Elp3 cKO n= 5; (u) WT n= 5; Elp3 cKO
n= 4. e p= 0.031, t= 2.407, df = 13. Source data are provided with this paper.
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anti-Acly antibodies and performing proximity ligation assay
(PLA) to reveal Acly puro-PLA puncta in PNs (Fig. 5c–d). We
showed comparable somatic and axonal Acly puro-PLA puncta in
PNs from both genotypes (Fig. 5e–f). Together, these data suggest
that loss of Elongator activity does not interfere with the trans-
lation of Acly mRNAs in cortical PNs.
We next tested whether the stability of ACLY might be impaired
upon loss of Elongator activity. For this purpose, we cultured
Fig. 3 Acly/ACLY expression rescues α-tubulin acetylation and molecular transport defects upon loss of Elongator activity in mouse and fly neurons.
a Immunolabeling and quantification of acetylated α-tubulin (Ac α-Tub) and total tubulin (Tot α-Tub) levels in axons of DIV5 cultured cortical PNs isolated
from E14.5 embryos and incubated with 10 mM hydroxy-citrate (HCA) during 8 h prior to fixation. Scale bar is 10 µm. b–d Time-lapse recording of axonal
transport in corresponding PNs cultured for 5 DIV in microfluidic devices and treated with vehicle- or HCA-supplemented medium for 8 h showing (av.)
velocity b, moving velocity c, and percentage of pausing time d of lysosomes (LysoTracker®). e Immunolabeling and quantification of acetylated α-tubulin
(Ac α-Tub) and total tubulin (Tot α-Tub) levels in MN axons from 3rd instar larvae of Drosophila melanogaster control or expressing Acly RNAi (Acly KD)
under a MN-specific driver (D42:GAL4). Scale bar is 10 µm. f–h Time-lapse recording of Synaptotagmin-GFP (Syt1-GFP) axonal transport in 3rd instar
larvae MNs of control or Acly KD to analyze average (av.) velocity f, moving velocity g, and percentage of pausing time h. i Immunolabeling and
quantification of acetylated α-tubulin (Ac α-Tub) and total tubulin (Tot α-Tub) levels in axons of cultured cortical PNs isolated from E14.5 WT and Elp3cKO
embryos transfected with Acly or control. Scale bar is 10 µm. j–l Cortical neurons isolated from E14.5 WT and Elp3cKO embryos were transfected with
control or ACLY expressing constructs and cultured for 5 DIV in microfluidic devices to perform time-lapse recording of axonal transport and measure
average (av.) velocity j, moving velocity k, and percentage of pausing time l of lysosomes (LysoTracker®). m Immunolabeling and quantification of
acetylated α-tubulin (Ac α-Tub) and total tubulin (Tot α-Tub) levels in MN axons of 3rd instar larvae: control, Elp3 KD, and Elp3 KD+ human ACLY. Scale
bar is 10 µm. n–p In vivo live imaging and behavior measurements in 3rd instar larva: control, Elp3 KD, and Elp3 KD+ human ACLY. n–p Time-lapse
recording of axonal transport of Synaptotagmin-GFP (Syt1-GFP) in MNs to analyze average (av.) velocity n, moving velocity o, and percentage of pausing
time p. Description of graphical summaries here within are histograms of means ± SEM. Significance was determined by: a two-sided t test, b–d two-sided
Mann–Whitney test, i two-sided one-way analysis of variance (ANOVA), and e, f, g, h, j, k, l two-sided Kruskal–Wallis one-way ANOVA. Specifically, [(a)
p= 0.0166, t= 2.445, df = 81; (b) p= 0.0039, U= 6807; (c) p= 0.2524, U= 2152 and p= 0.0032, U= 4559 for anterograde and retrograde,
respectively; (d) p < 0.0001, U= 6201; (e) p < 0.0001, K= 26.17; (f) p < 0.0001, K= 55.55; (g) p= 0.0130, K= 8.69 and p= 0.0004, K= 15.55 for
anterograde and retrograde, respectively; (h) p < 0.0001, K= 93.1; (i) p= 0.0042, F= 4.969; (j) p < 0.0001, K= 28.69; (k) p= 0.001, K= 13.85 and
p < 0.0001, K= 251.5; (l) p < 0.0001, K= 24.74; (m) p= 0.0003, F= 9.158; (n) p < 0.0001, K= 21.66; (o) p < 0.0001, F= 25.90, and p < 0.0001,
F= 20.96 for anterograde and retrograde, respectively; (p) p < 0.0001, K= 22.35. In addition, the post hoc multiple comparisons, to analyze statistical
difference of each condition compared to control for (e) Kruskal–Wallis test, for (i, m) is Dunnet’s test, for (f, g, h, j, k, l, n, o, p) are Sidak’s test and are
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. a Number of axons: Vehicle n= 88; 10mM HCA n= 151; 2 mice per group. b) Number of axons:
Vehicle n= 133; 10 mM HCA n= 129. 2 mice per group. c Number of vesicles: Vehicle n= 63 (anterograde), n= 113 (retrograde); 10 mM HCA n= 77
(anterograde), n= 105 (retrograde). d Number of vesicles: Vehicle n= 133; 10 mM HCA n= 129. e Number of axons: Control n= 9; Acly KD n= 9;
Acly;Hdac6 KD n= 9. 6 larvae per group. f Number of vesicles: Control n= 234; Acly KD n= 422; Acly;Hdac6 KD n= 182. 3 animals per group. g Number
of vesicles: Control n= 131 (anterograde), n= 134 (retrograde); Acly KD n= 195 (anterograde), n= 337 (retrograde); Acly;Hdac6 KD n= 89
(anterograde), n= 119 (retrograde). h Number of vesicles: Control n= 234; Acly KD n= 422; Acly;Hdac6 KD n= 182. i Number of axons: WT+ Control
n= 28; Elp3 cKO+ Control n= 25; Elp3 cKO+Acly n= 23. Number of mice per group: WT+Control n= 5; Elp3 cKO+ Control n= 3; Elp3 cKO+Acly
n= 5. j Number of vesicles: WT+ Control n= 441; Elp3 cKO+Control n= 429; Elp3 cKO+Acly n= 385. Number of mice per group: WT+Control
n= 5; Elp3 cKO+ Control n= 3; Elp3 cKO+Acly n= 5. k Number of vesicles: WT+Control n= 108 (anterograde), n= 143 (retrograde); Elp3
cKO+ Control n= 111 (anterograde), n= 79 (retrograde); Elp3 cKO+Acly n= 103 (anterograde), n= 107 (retrograde). Number of mice per group:
WT+ Control n= 5; Elp3 cKO+ Control n= 3; Elp3 cKO+Acly n= 5. l Number of vesicles: WT+ Control n= 441; Elp3 cKO+Control n= 429; Elp3
cKO+Acly n= 385. Number of mice per group: WT+ Control n= 5; Elp3 cKO+ Control n= 3; Elp3 cKO+Acly n= 5. m Number of axons: Control
n= 25; Elp3 KD n= 10; Elp3 KD+Acly n= 37. 3 mice per group. n Number of vesicles: Control n= 304; Elp3 KD n= 78; Elp3 KD+Acly n= 181. Number
of larvae per group: Control n= 5; Elp3 KD n= 10; Elp3 KD+Acly n= 10. o Number of vesicles: Control n= 87 (anterograde), n= 141; Elp3 KD n= 99
(anterograde), n= 141 (retrograde); Elp3 KD+Acly n= 80 (anterograde); n= 81 (retrograde). Number of larvae per group: Control n= 5; Elp3 KD n= 10;
Elp3 KD+Acly n= 10. p Number of vesicles: Control n= 252; Elp3 KD n= 84; Elp3 KD+Acly n= 234. Source data are provided with this paper.
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patient fibroblasts and performed cycloheximide chase assay to
measure ACLY half-life in several lines of control and FD
fibroblasts. We showed a reduction of ACLY stability in FD
fibroblasts as compared to control lines (Fig. 5g–h), a phenotype
that may result from the disruption of an interaction between the
Elongator and Acly, as suggested by co-immunoprecipitation
experiments performed in HEK293 cells (Supplementary Fig. 5a).
Altogether, these data suggest that loss of Elongator activity reduces
Acly/ACLY stability, thereby affecting the local production of
acetyl-CoA required by ATAT1 to promote MT acetylation. Such
regulation is likely to take place in motile vesicles (Fig. 5i).
Discussion
Here, we show that loss of Elongator activity impairs both the MT
acetylation and bidirectional axonal transport in mouse cortical
neurons in culture, as well as in fly motoneurons in vivo,
ultimately resulting in locomotion deficits in flies. These defects
are similar to those observed upon loss of Atat1 expression, the
enzyme that catalyzes the acetylation of α-tubulin K40 residues in
MTs. This shared phenotype prompted us to investigate a pos-
sible coordination between the Elongator and Atat1 in the control
of MT-dependent axonal transport via α-tubulin acetylation. By
combining conditional loss of function models with genetic
experiments, we observed a molecular cooperation between
Elongator and Atat1 and identified Acly as the common
denominator, which provides acetyl groups from Acetyl-CoA to
vesicular Atat1 and whose expression depends on Elongator
activity. We showed that acute knockdown or pharmacological
blockade of Acly impairs MT acetylation and axonal transport in
fly and mouse, respectively. Here, the lower effect of HCA
treatment on lysosome axonal transport may reflect a sub-
efficient reduction of Acetyl CoA availability in mouse PNs, as
Fig. 4 ACLY expression rescues defects of α-tubulin acetylation and microtubule-dependent transport in human FD fibroblasts. a Immunoblotting of
ACLY and ß-ACTIN in cultured human primary fibroblast extracts from Control and FD patients. b Immunolabeling and quantification of acetylated α-
tubulin and total tubulin levels in primary fibroblasts from healthy controls and FD patients incubated with the ACLY inhibitor hydroxy-citrate acid (HCA).
Scale bar is 50 µm. c Immunolabeling and quantification of acetylated α-tubulin and total α-tubulin levels in extracts from primary fibroblasts from healthy
controls and FD patients transfected with control or ACLY expressing plasmids. Scale bar is 50 µm. d–f Time-lapse recording of MT-dependent transport of
lysosome (LysoTracker®) in fibroblasts from Control or FD patients, transfected with Control or ACLY plasmids, to analyze average (av.) velocity (d),
moving velocity (e) and percentage of pausing time (f). Description of graphical summaries here within are histograms of means ± SEM. Significance was
determined by: (a) two-sided t test, (b) two-sided two-way analysis of variance (ANOVA), (c) two-sided ANOVA, and (d, e, f) two-sided Kruskal–Wallis
one-way ANOVA. Specifically, [(a) p= 0.0467, t= 2.181, df = 14; (b) p= 0.0038, Finteraction (2, 109)= 5.876; (c) p < 0.0001, F= 13.17; (d) p < 0.0001,
K= 48.95; (e) p < 0.0001, K= 35.10; (f) p < 0.0001, K= 40.98. In addition, the post hoc multiple comparisons to analyze statistical difference of each
condition compared to control for (b) is Sidak’s test, for (c) is Dunnet’s test, for (d, e, f) are Dunn’s test, and are *p < 0.05, ***p < 0.001, and ****p < 0.0001.
a 5 human primary fibroblast lines per group. b Number of cells: Control n= 26 (Vehicle), n= 18 (3 mM HCA), n= 20 (10mM HCA); FD n= 18 (Vehicle),
n= 15 (3 mM HCA), n= 18 (10mM HCA). Number of fibroblast lines per group: Control n= 5; FD n= 4. c Number of cells: Control+ EV n= 15; FD+ EV
n= 15; FD+Acly n= 15. d Number of vesicles: Control+ EV n= 262; FD+ EV n= 217; FD+Acly n= 143. 5 human primary fibroblast lines per group.
e Number of vesicles: Control+ EV n= 133; FD+ EV n= 68; FD+Acly n= 89. 5 human primary fibroblast lines per group. f Number of vesicles:
Control+ EV n= 251; FD+ EV n= 217; FD+Acly n= 143. 5 human primary fibroblast lines per group. Source data are provided with this paper.
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compared to the one obtained in the genetic fly model. On the
other hand, raising Acly level not only rescued axonal transport
defects in both mouse and fly Elongator models but also
improved locomotion activity of Elp3 KD larvae and flies. We
found that loss of Elongator activity does not affect the tran-
scription and translation of Acly but rather impairs Acly/ACLY
stability. Our in vitro data suggest that Elongator may regulate
Acly/ACLY protein stability via molecular interaction, as pre-
viously reported for other cytoplasmic proteins37 (Supplementary
Fig. 5). Another non-mutually exclusive mechanism that may act
downstream Elongator would involve the regulation of the
acetyltransferase47 P300/CBP-associated factor (PCAF),
which is known to increase Acly stability by promoting its
acetylation47.
We previously showed that motile vesicles are the main driver
of MT acetylation in axons30 and Elongator subunits and Atat1
have been detected in protein extracts from purified motile
vesicles16,30. Here, we found that the vesicular fraction isolated
from mouse cerebral cortical extracts does not only express
Elongator subunits and Atat1, but it is also enriched with a
functional pool of Acly (Fig. 2j–l). Therefore, we postulate that an
Elongator/Acly/Atat1 (EAA) signaling pathway may directly act
at vesicles to promote MT acetylation, further supporting their
non-canonical role as a platform for local signaling and for
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regulating axonal transport in particular (Fig. 5i). Since these
molecules are also detected in the cytosolic fraction together with
Acss2 (S3, Fig. 2j–l), whose expression is reduced upon loss of
Elongator (Fig. 2f, h), we cannot rule out the contribution of some
cytosolic Acetyl-CoA generated by Acss2 in the vicinity of MTs,
which would explain the remaining basal level of MT acetylation
seen upon axonal transport blockade30. We observed comparable
defects of α-tubulin acetylation and MT-dependent transport in
fly, mouse, and human cells lacking Elongator activity, which,
together with similar observations made in C. elegans6, suggest a
strong functional conservation of the EAA pathway across
species.
A tight control of axonal transport is indeed very important to
ensure the homeostatic activity of neurons by delivering cargos to
distant regions, thereby controlling cytoskeleton maintenance as
well as spreading long-range intracellular signaling that ensures
cellular maintenance and function. Impairment of axonal trans-
port is considered as an early pathological feature shared by sev-
eral neurodegenerative disorders2,48,49. Along this line, our results
obtained with FD fibroblasts support those previously described in
neurons28 and suggest that loss of Elongator activity contribute to
neurodegeneration by interfering at least with MT-dependent
transport in FD patients via impairment of ACLY expression. We
did not observe differences in MT deacetylation activity in FD and
WT fibroblasts (Supplementary Fig. 4h), suggesting that reduction
of MT acetylation in FD fibroblasts does not arise from changes of
HDAC6 expression, in contrast to what others have reported28.
More generally, α-tubulin acetylation not only modulates
axonal transport but also provides resistance to mechanical
bending to MTs50. Therefore, by controlling the cytoskeleton
integrity and function, the EAA pathway likely acts as a key
regulator of neuronal fitness whose progressive dysfunction may
contribute to neuronal aging and even underlie neurodegenera-
tion. Thus, targeting this molecular pathway may open ther-
apeutic perspectives to prevent the onset or the progression of
neurodegenerative disorders like FD characterized by poor axonal
transport and degeneration.
Methods
Mice. All experiments performed in this study adhere to all relevant ethical reg-
ulations for animal testing and research. The animal work was approved by the
ethical committee of the University of Liege under the license #18-2056.
Brains were harvested from mice at P0-P2 or E14.5. FoxG1:Cre −/+/Elp3 lox/+
and Elp3 lox/lox mice were time-mated to induce a conditional deletion of Elp3 in
the forebrain progenitors33. Brains were harvested from 10–16 months-old
Elp1cKO and WT mice27. Atat1 +/− mice were crossed together to obtain WT and
KO mice51. Mice were housed under standard conditions (animals were bred in-
house and maintained with ad libitum access to food and constant temperature
(19–22 °C) and humidity (40–50%) under a 7am–7 pm light/dark cycle) and they
were treated according to the guidelines of the Belgian Ministry of Agriculture in
agreement with the European Community Laboratory Animal Care and Use
Regulations (86/609/CEE, Journal Official des Communautés Européennes L358,
18 December 1986). Neuronal cultures were prepared from dissected E14.5 mice
brain cortices, followed by mechanical dissociation in HBBS (Sigma–Aldrich,
H6648) supplemented with 1.5% glucose. Cells were cultured at confluence of
~70% (for 5 days) with Neurobasal Medium (Gibco, Invitrogen, 21103049)
supplemented with 2% B27 (Gibco, Invitrogen, 17504044), 1% Pen/Strep (Gibco,
Invitrogen, 15140122), and 1% Glutamax (Gibco, Invitrogen, 35050061) at 37 °C.
Drosophila melanogaster. Flies were kept at 25 °C in incubator with regular 12-h
light and dark cycle. All crosses were performed at 25 °C, after two days hatched
first instar larvae were transferred in a 29 °C incubator until use.
UAS-RNAi carrying lines were crossed with D42-Gal4-UAS:Syt1-GFP virgin
females for axonal transport recording and immunohistochemistry, with D42-Gal4
for behavioral experiments, or with Elav-Gal4 for qPCR and WB analysis (See
Table 1). All RNAi inserts sequences were validated by DNA sequencing.
Human primary fibroblasts. Fibroblasts were cultured on polystyrene culture
flasks (Corning) at 37 °C with 5% CO2 in DMEM (Gibco, Invitrogen, 11965092)
medium supplemented with 10% Fetal Calf Serum (Gibco, Invitrogen, 10500056),
1 mM Sodium pyruvate (Gibco, Invitrogen, 11360070), 1 mM non-essential amino
acids (Gibco, Invitrogen, 11140050). Primary fibroblasts from five FD patients and
age-matched controls were purchased from Coriell biobank (www.coriell.org)
(Table 2).
Immunofluorescence. E14.5 cortical neurons were plated on coverslips in 24 well
plate at a density of 30,000 cells and cultured for 5DIV. Neurons were fixed by
incubation in 4% PFA-sucrose in PBS for 20 min at RT and washed with PBS+
0.3% Triton-X. After washing, neurons were incubated in blocking solution
(PBS+ 0.3% Triton-X+ 10% normal donkey serum) for 1 h at RT. Following
overnight incubation with primary antibodies in blocking solution at 4 °C, washing,
and incubation with secondary antibodies (PBS+ 0.3% Triton-X+ 1% normal
donkey serum) at RT for 1 h and washing, coverslips were then mounted on
microscope slide using Mowiol. Images were acquired using a Nikon A1Ti confocal
microscope (60x oil lens) or Airyscan super-resolution module on a Zeiss LSM-880
confocal (63x oil lens).
Larvae were dissected in PBS to expose the brain and MNs. After dissection
larvae were fixed with 4% PFA for 20 min at RT, washed with PBS+ 0.2% (CSP
staining) or 0.3% (α-Tubulin acetylation staining) Triton-X and incubated in
blocking solution PBS, 0.2% (CSP staining), or 0.3% (α-Tubulin acetylation
staining) Triton-X+ 1% BSA for 30 min at RT. Following overnight incubation
with primary antibodies at 4 °C, washing and incubation with secondary antibodies
at RT for 2 h, the larvae were mounted on microscope slide in Mowiol. Images were
acquired using a Nikon A1Ti confocal microscope (60x oil lens).
Primary fibroblasts from FD patients or controls were plated at the
concentration of 5000 cells in a 96-well plate (uClear, Grinere). Cells were fixed
with 4% PFA for 10 min, washed, permeabilized, and blocked for 1 h at RT with 5%
fetal bovine serum in PBS+ 0.1% Triton-X. Following overnight incubation with
acetylated α-tubulin (Sigma-Aldrich) and β-tubulin (cell signaling) antibodies, cells
were washed with PBS+ 0.05% Triton-X times and incubated with secondary
antibodies for 1 h at RT. Finally, the cells were washed, and remained in PBS for
image acquisition. Images were acquired using a IN Cell Analyzer 2200 fluorescent
microscope (General Electric) using a 60x air lens.
Fluorescence intensity levels were measured by Fiji (https://imagej.net/Fiji/
Downloads). To analyze α-tubulin and acetylated α-tubulin levels of mice cortical
neuron axons and fly MNs, ROIs of 30 µm long axonal segments accounting for
their full width were used. For human primary fibroblasts, ROI of the entire cell
were outlined. α-tubulin and acetylated α-tubulin levels were extracted from mean
intensity levels. Background levels were subtracted and the ratio of acetylated α-
tubulin/α-tubulin was calculated.
Fig. 5 Elongator depletion reduces the stability but not translation of Acly. a–b Transcriptional and translational analysis of Acly mRNA in cortex lysate from
newborn WT and Elp3 cKO mice. qPCR quantification of Acly mRNA normalized to GAPDH obtained from lysed cortex (total) (a) or from polysomal fraction
(polysomal) enriched by sucrose gradient ultracentrifugation of cytoplasmic cortical lysate (b) (values are means ± SEM; unpaired t test). c–f Analysis of local
translation events of Acly in cultured cortical PNs from E14.5 WT and Elp3cKO embryos. Schematic of the puro-PLA principle to visualize newly synthesized
peptides (c). Representative images of newly synthesized Acly in cortical PNs cultured five days in vitro and treated 4min with puromycin before fixation and
processing for puro-PLA; puro-Acly PLA puncta (green), α-tubulin (purple) (d). Quantification of somal puro-PLA fluorescence intensity normalized to α-tubulin
(e) and axonal number of puro-PLA puncta over 100μm segments (f) (values are means ± SEM; unpaired t test). Scale bar is 20 μm (top panels) and 10 μm
(bottom panels). g–h Immunoblotting and quantification of ACLY and GAPDH in human primary fibroblast extracts from Control and FD patients incubated with
cycloheximide (CHX, 50 μg/mL) for 0, 4, 6, and 8 h. i Summary scheme showing a central role played by Acly in the control of both α-tubulin acetylation and
microtubule-dependent transport, which are impaired upon loss of Elongator activity. Description of graphical summaries here within are histograms of
means ± SEM. Significance was determined by: (a, b, e, f) two-sided t test, (e) two-sided two-way ANOVA. Specifically, [(a) p=0.8244, t=0.2318, df = 6; (b)
p=0.9303, t=0.9114, df = 6; (e) p=0.3160, t= 1.03, df= 19; (f) p=0.5484, t=0.6141, df = 15; (h) p < 0.0034, FInteraction (1, 22)= 10.78). (a, b) 4 animals
per group. e Number of axons: WT n= 10; Elp3 cKO n= 11. 2 animals per group. f Number of axons: WT n= 8; Elp3 cKO n= 9. 2 animals per group. h 4 human
primary fibroblast lines per group. Source data are provided with this paper.
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Vesicular and mitochondrial transport recording in vitro and in vivo. Axonal
transport in mice cultured cortical neurons was recorded in microfluidics
devices, prepared as described in52. Briefly, air bubbles were removed from
mixed sylgard 184 elastomer (VossChemie Benelux, 1:15 ratio with curing agent)
by centrifuging at 1000 × g for 5 min. The liquid was poured into the micro-
fluidic device mold and was cured by 3 h incubation at 70 °C incubator. Molds
were cut and washed twice with 70% ethanol, air dried in biological hood and
placed on 35 mm glass-bottom dishes (MatTek, P35G-0-20-C) previously coated
with 0.1 mg/mL poly-D-lysine (overnight incubation at 4 °C prior to washes and
air drying). To increase the adhesiveness, the microfluidic chambers and dishes
were heated to 70 °C before assembling. E14.5 mouse cortical neurons were
isolated and resuspended at 40000 × 103 cells/μL for seeding at a 70% confluency
into the microfluidic somal channel. After plating, the axonal and somal com-
partments of the microfluidic devices were filled with culture medium supple-
mented with 50 ng/ml or 20 ng/ml BDNF (PeproTech, 450-02), respectively.
Labeling were done on after 5DIV by adding 1 µM LysoTracker® Red DND-99
(ThermoFisher Scientifics, L7528), MitoTracker® Green FM (ThermoFisher
Scientifics, M7514) or MitoTracker® Deep Red FM (ThermoFisher Scientifics,
M22426) 30 min prior to time-lapse recordings. Axonal transport recording in
Drosophila Melanogaster MNs were done on 3rd instar larvae expressing
UAS:RNAi and Syt1-GFP. Larvae were anaesthetized with ether vapors (8 min)
and mounted dorsally on microscope slide using 80% glycerol. Recordings of
mice cortical neurons and Drosophila melanogaster MNs were performed on an
inverted confocal microscope Nikon A1Ti (60x oil lens) or Zeiss LSM-880
confocal (63x oil lens) at 600 ms frame interval.
Intracellular transport in human primary fibroblasts was recorded 3 days
after plating, by adding 1 µM LysoTracker® Red DND-99 (ThermoFisher
Scientifics, L7528) 30 min prior to time-lapse recordings. Recordings of
human primary fibroblasts were performed using in-cell 2200 (General Electric)
using 60X air lens, at 2 s frame intervals, using temperature (37 °C) and CO2
control.
Video analysis was performed by generation of kymographs for single-blind
analysis using ImageJ plugin-KymoToolBox (fabrice.cordelieres@curie.u-
psud.fr). Average velocity is defined as the cumulative distance traveled by an
organelle divided by the total amount of time, therefore it includes the pausing
time. Moving velocity is defined by the cumulative distance traveled anterograde
or retrograde divided by the time traveled anterograde or retrograde, therefore it
excludes the pausing time. Moving velocity for anterograde is represented by
positive values and retrograde by negative values. Pausing time is defined as the
percentage of time that an organelle spends at a velocity lowered than 0.1 μm/sec
out of the total traveling time. All kymographs show anterograde (left to right
direction) and retrograde (right to left) moving vesicles. For analysis of axonal
transport in Drosophila melanogaster, the StackReg plugin was used to align
frames.
Plasmids and drug treatments. For silencing of Elp3 in mouse cortical neurons
we inserted sh-Elp3 5’GCACAAGGCUGGAGAUCGGUU3’ or a control sequence
sh-Control 5′-TACGCGCATAAGATTAGGG-3′ previously described in25,53. The
viral packaging vector is PSPAX2 and the envelope is VSV-G. The lentiviral vector
is pCDH-cmv-EF1-copGFP (CD511B1), and the promotor was replaced by a U6
promoter. For expression of human ACLY in E14.5 mice cortical neurons, cells in
suspension were transfected with pEF6-Acly (Addgene plasmid # 70765, a gift from
Kathryn Wellen)54 or pEF6 (control) and GFP (from VPG-1001, Lonza) using
Mouse Neuron Nucleofector® Kit (VPG-1001, Lonza) according to the manu-
facturer’s protocol. GFP-positive neurons were used for analysis. To assay the
subcellular localization of Acly in respect to lamp1-positive late endosomes/lyso-
somes in mouse cortical neurons, pCAG mEmerald-LAMP1 provided by F. Polleux
(Columbia University, New York, USA) was transfected using Mouse Neuron
Nucleofector® Kit (VPG-1001, Lonza) according to manufacturer’s protocol. For
expression of human ACLY in cultured human primary fibroblasts, cells were
transfected with pEF6-Acly (Addgene plasmid # 70765, a gift from Kathryn
Wellen)54 or pEF6 (control) and GFP (from VPG-1001, Lonza) using Lipofecta-
mine® 2000 according to manufacturer’s protocol. GFP-positive cells were used for
analysis. Tubastatin A (TBA, 20 μM) or Hydroxy-citrate (HCA, 3 mM or 10 mM)
were dissolved in Ultra-Pure Water (UPW) and added to cell cultures 2 h or 8 h,
respectively, prior to recording.
Real-time quantitative PCR analysis (qRT-PCR). One mouse cortex or ten adult
fly heads were collected in TRIzol Reagent (Ambion, Life Technologies) followed
by RNA extraction performed following the manufacturer’s instructions. After
DNAse treatment (Roche), 1 μg of RNA was reverse transcribed with RevertAid
Reverse Transcriptase (Fermentas). RT-qPCR was performed using Quant Studio
(Thermo) and TaqMan primers for mice, or a Light Cycler 480 (Roche) with Syber
Green mix for Drosophila melanogaster. Analyses were done using the 2-ΔΔCT
method55 with the primers listed in Table 3.
Protein aggregation assay. Cultured mice cortical neurons or human primary
fibroblasts at 60% confluency were incubated with PROTEOSTAT® (Enzo Life-
Sciences) to detect protein aggregates.
Locomotion activity and climbing assays. Larval crawling speed assays were
performed by placing 3rd instar larvae in the center of 15-cm petri dishes coated
with 3% agar, as previously published56. Velocities were extrapolated by measuring
the distance traveled in 1 min. The climbing assay was performed as previously
described in57, by measuring the average ratio of successful climbs over 15 cm for
10 adult flies.
Western blot. Mouse brain cortices, adult fly heads, or human primary fibroblasts
were quickly homogenized on ice in RIPA buffer, or 320 mM sucrose, 4 mM
HEPES buffer for subcellular fractions. Protease inhibitor cocktail (Roche, P8340 or
Sigma-Aldrich, S8820) and 5 μM Trichostatin-A (Sigma-Aldrich, T8552) were
added to inhibit protein degradation and α-tubulin deacetylation.
Immunoblotting was performed with the primary and secondary antibodies
listed in Supplementary Table 1. We used 2 μg of protein lysate for α-tubulin
acetylation analysis and 20–30 μg for all other proteins. Nitrocellulose membranes
were imaged using Amersham Imager 600 (General Electric, 29083461) and band
densitometry was measured using FIJI.
Subcellular fractionation. Subcellular fractionation of frozen mice brain cortex
was performed as previously described30. Tissues or cells were homogenized in
320 mM sucrose, 4 mM HEPES, pH 7.4 (fractionation buffer). The homogenate
was centrifuged for 10 min at 1000 × g to obtain a pellet (P1) (nuclear fraction) and
a post-nuclear fraction (S1). The supernatant (S1) was centrifuged for 40 min at
12,000 × g to obtain large membranes (P2) and vesicle-enriched cytosolic fraction
(S2). Finally, S2 was centrifuged again for 90 min at 120,000 × g using a TLA 120.1
fixed angle rotor in Optima TLX Benchtop Ultracentrifuge to obtain vesicle
Table 2 Human fibroblast lines.
Catalog number Sex Age Sample description
GM02036 Female 11 Apparently Healthy
GM07492 Male 17 Apparently Healthy
GM07522 Female 19 Apparently Healthy
GM038 Female 3 Apparently Healthy
GM05659 Male 14 Apparently Healthy
GM02343 Female 24 Familial Dysautonomia
GM04589 Male 16 Familial Dysautonomia
GM04663 Female 2 Familial Dysautonomia
GM04959 Female 10 Familial Dysautonomia
GM04899 Female 12 Familial Dysautonomia
Table 1 Drosophila melanogaster lines.
Line Catalog number Given name Purchased from
Elav-Gal4 BDSC 458 Bloomington Drosophila Stock Center
huD42-Gal4 BDSC 8816 Bloomington Drosophila Stock Center
UAS:Syt-GFP BDSC 6925 Bloomington Drosophila Stock Center
UAS:RNAi Zpg VDRC CG10125 Control Vienna Drosophila Resource Center
UAS:RNAi Elp1 VDRC CG10535 Elp1 KD Vienna Drosophila Resource Center
UAS:RNAi Elp3 VDRC CG15433 Elp3 KD Vienna Drosophila Resource Center
UAS:RNAi Atat1 VDRC CG3967 Atat1 KD Vienna Drosophila Resource Center
UAS:RNAi Hdac6 BDSC 51181 Hdac6 KD Bloomington Drosophila Stock Center
UAS:Human Elp3 hElp3 Kindly provided by Patrick Verstreken
UAS:Human ACLY VDRC CG8322 hACLY Vienna Drosophila Resource Center
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fraction (P3) and a cytosolic fraction (S3). The vesicle fraction was gently washed
once with fractionation buffer, and resuspended by vigorous pipetting with the
same buffer.
Mass spectrometry analysis. Pellets from three independent samples of pooled
vesicles isolated from the brain cortex of WT or Elp1 KD mice were solubilized
using 5% SDS. The samples were dissolved in 10 mM DTT 100 mM Tris and 5%
SDS, sonicated, and boiled at 95 °C for 5 min. The samples were precipitated in
80% acetone. The protein pellets were dissolved in 9M Urea and 100 mM
ammonium bicarbonate than reduced with 3 mM DTT (60 °C for 30 min), mod-
ified with 10 mM iodoacetamide in 100 mM ammonium bicarbonate (room tem-
perature for 30 min in the dark), and digested in 2 M Urea, 25 mM ammonium
bicarbonate with modified trypsin (Promega), overnight at 37 °C in a 1:50 (M/M)
enzyme-to-substrate ratio. The resulting tryptic peptides were desalted using C18
tips (Harvard) dried and resuspended in 0.1% Formic acid. Samples were analyzed
by LC-MS/MS using Q Exactive plus mass spectrometer (Thermo) fitted with a
capillary HPLC (easy nLC 1000, Thermo). The peptides were loaded onto a
homemade capillary column (20 cm, 75 micron ID) packed with Reprosil C18-
Aqua (Dr Maisch GmbH, Germany) in solvent A (0.1% formic acid in water). The
peptides mixture was resolved with a (5 to 28%) linear gradient of solvent B (95%
acetonitrile with 0.1% formic acid) for 60 min followed by a gradient of 28–95% for
15 min, and 15 min at 95% acetonitrile with 0.1% formic acid in water at flow rates
of 0.15 μl/min. Mass spectrometry was performed in a positive mode using repe-
titively full MS scan followed by high collision-induced dissociation (HCD, at 35
normalized collision energy) of the 10 most dominant ions (>1 charges) selected
from the first MS scan. The mass spectrometry data were analyzed using the
MaxQuant software 1.5.1.2. (//www.maxquant.org) using the Andromeda search
engine, searching against the mouse uniprot database with a mass tolerance of 20
ppm for the precursor masses and 20 ppm for the fragment ions. Peptide- and
protein-level false discovery rates (FDRs) were filtered to 1% using the target-decoy
strategy. Protein table were filtered to eliminate the identifications from the reverse
database, and common contaminants and single peptide identifications. The data
were quantified by label-free analysis using the same software, based on extracted
ion currents (XICs) of peptides enabling quantitation from each LC/MS run for
each peptide identified in any of the experiments. The mass spectrometry pro-
teomics data have been deposited to the ProteomeXchange Consortium via the
PRIDE partner repository with the dataset identifier PXD021186.
In vitro α-tubulin assay. In vitro α-tubulin acetylation assay was performed as
previously described30. Briefly, 96-well half-area plates (Greiner, 674061) were
coated with 5 µg tubulin from HeLa cells or bovine brain (Cytoskeleton, catalog no.
HTS02-A) in 25 µL of ultrapure water for 2.5 h at 37 °C, blocked (PBS+ 3%
BSA+ 3% skim milk + 3% FBS) for 1 h at 37 °C, and washed with PBS+ 0.05%
Tween 20. Wells were incubated for 2 h at 37 °C with shaking at 140x g with 25 µg
of the total, S2, S3, or P3 fractions isolated from P0 mouse brain cortex previously
diluted in 2× histone acetyltransferase (HAT) buffer (Sigma–Aldrich, EPI001A)
supplemented with protease inhibitor cocktail, 5 µM trichostatin, and 50 µM
acetyl-CoA (Sigma-Aldrich, A2056) or vehicle (H20) for control. After washes and
overnight incubation at 4 °C with acetylated a-tubulin antibody (1:2000) in
blocking buffer (PBS+ 0.05% Tween 20+ 3% BSA), wells were washed and
incubated for 2 h at 37 °C with peroxidase-conjugated goat antimouse antibody
(1:5000) in antibody blocking buffer. Wells were then washed and incubated with
trimethylboron/E (Merck Millipore, ES001) whose reaction was thereafter stopped
with H2SO4. Following the manufacturer’s instructions, the HAT activity colori-
metric assay kit (Sigma–Aldrich, EPI001) was used to measure CoA release.
α-Tubulin deacetylation assay. α-Tubulin deacetylation assay was performed as
previously described in38. Briefly, 96-well half-area plates (Greiner, 674061) were
coated with 1 μg tubulin in 50 μl of ultra-pure water for 2.5 h at 37 °C, followed by
blocking (PBS, 3% BSA, 3% skim milk, 3% fetal bovine serum) for 1 h at 37 °C, and
washing with PBS+ 0.05% Tween-20. 10 μg of cytosolic fraction isolated from
newborn mice brain cortex in deacetylation buffer (50 mM Tris-HCl at pH 7.6,
120 mM NaCl, 0.5 mM EDTA) supplemented with protease inhibitor cocktail and
phosphatase inhibitor (to avoid dephosphorylation of HDAC6) were added per
well for incubation of 4 h at 37 °C with shaking at 120x g. The wells were washed
and incubated overnight at 4 °C with acetylated α-tubulin antibody (1:2000) in
blocking buffer (PBS+ 0.05% Tween-20+ 3%BSA). Wells were subsequently
washed and incubated for 2 h at 37 °C with Peroxidase-conjugated Goat antimouse
antibody (1: 5000) in antibody blocking buffer. After the final washes, the perox-
idase activity was probed with TMB/E (ES001, Merck Millipore), and the reaction
stopped with H2SO4.
Acly activity assay. Acly activity assay was measured as previously described in41.
Briefly, cells or brain extracts were disrupted by passing them 15 times in 25-gauge
needle in 100 mM Tris-HCL buffer, supplemented with protease and phosphatase
inhibitors. 5ug of cells/brain lysate were added to the reaction mix (200 mM Tris-
HCL pH 8.4, 20 mM MgCl2, 20 mM sodium citrate, 1 mM DTT, 0.1 mM NADH
(Sigma-Aldrich, N8129), 6 U/mL Malate dehydrogenase (Sigma-Aldrich, M1567),
0.5 mM CoA (Sigma-Aldrich, C3019) with or without ATP (Sigma-Aldrich,
A1852). Acly activity was measured every 100 s for 4 h, in the volume of 50ul in a
384 well plate using 340 nm OD read. Acly specific activity was calculated as the
change in absorbance in the presence or absence of ATP. For statistical comparison
Acly activity was defined as the slope from the linear range of the reaction.
Acetyl-CoA sample preparation and LC-MS/MS analysis. Acetyl-CoA was
extracted as previously described58. Briefly, cold methanol (500 μl; −20 °C) was
added to the cell pellets, and the mixture was shaken for 30 s (10 °C, 2000 r.p.m.,
Thermomixer C, Eppendorf). Cold chloroform (500 μl; −20 °C) was added, the
mixture was shaken for 30 s, and 200 μl of water (4 °C) added afterwards. After 30 s
shaking and 10 min on ice, the mixture was centrifuged (21,000 × g, 4 °C, 10 min).
The upper layer was collected and evaporated. The dry residue was re-dissolved in
eluent buffer (500 μl) and centrifuged (21,000 × g, 4 °C, 10 min) before placing in
LC-MS vials. Acetyl CoA was analyzed as previously described59. Briefly, the LC-
MS/MS instrument consisted of an Acquity I-class UPLC system and Xevo TQ-S
triple quadrupole mass spectrometer (both Waters) equipped with an electrospray
ion source. LC was performed using a 100 × 2.1-mm i.d., 1.7-μm UPLC Kinetex
XB-C18 column (Phenomenex) with mobile phases A (10 mM ammonium acetate
and 5 mM ammonium hydrocarbonate buffer, pH 7.0, adjusted with 10% acetic
acid) and B (acetonitrile) at a flow rate of 0.3 mLmin-1 and column temperature of
25 °C. The gradient was set as follows: 0–5.5 min, linear increase 0–25% B, then
5.5–6.0 min, linear increase till 100% B, 6.0–7.0 min, hold at 100% B, 7.0–7.5 min,
back to 0% B, and equilibration at 0% B for 2.5 min. Samples kept at 4 °C were
automatically injected in a volume of 5 μl. Mass spectrometry was performed in
positive ion mode, monitoring the MS/MS transitions m/z 810.02→ 428.04 and
810.02→ 303.13 for acetyl-CoA. Spikes of defined amounts of AcCoA were added
to the samples to confirm the absence of signal inhibition (matrix effect) in the
analyzed extracts. Quantification of AcCoA was done against an external calibra-
tion curve with 1–1000 ng mL–1 range of AcCoA concentrations using TargetLynx
software (Waters).
Polysomal fractionation. Polysome-bound RNA was purified from the cortical
extract of P0 pups according to Laguesse et al.45. Briefly, fresh mouse cortex was
snap-frozen in 1.5 mL Eppendorf tube, pulverized in liquid nitrogen with a pestle,
and kept on dry ice for 5 min. The powder was resuspended in 1 mL lysis buffer
(10 mM Trish pH 8.0, 150 mM NaCl, 5 mM MgCl2, 1% NP-40, 0.5% sodium
deoxycholate, 40 mM dithiothreitol, 10 mM Ribonucleoside Vanadyl Complex,
200 µg/mL cycloheximide and 400 U/mL RNAsin). 200 µL of the homogenate was
used to isolate total RNA using TRIzol reagent. The remaining 800 µL were cen-
trifuged for 10 s at 12.000 × g to discard nuclei, and the supernatant was collected.
Ribosomes were further released by adding 800 µL of 2X extraction buffer (200 mM
Tris pH 7.5, 300 mM NaCl, and 200 µg/mL cycloheximide) and samples were
centrifuged at 12,000 × g for 5 min at 4 °C to remove mitochondria and mem-
branous debris. The resulting supernatant was loaded onto a 8 mL 15–45% sucrose
gradient and centrifuged at 100,000 × g (at rmin), 4 °C for 2 h without brake, by
using a SW4Ti rotor (Beckman Coulter). The four first 500 µL bottom fractions
were collected and digested with proteinase K buffer (400 µg/mL Proteinase K,
10 mM EDTA, 1% SDS) at 37 °C for 30 min, to be thereafter extracted with phenol-
chloroform. Polysomal fractions were assayed for purity by assessing the presence
of 28 S and 18 S ribosomal RNA bands on an agarose gel, and by measuring
absorbance at 254 nm, as previously described60.
Puro-PLA and immunostaining. Puro-PLA was performed as previously
described61 to label newly synthesized proteins of interest. In brief, neurons cul-
tured 5 days in vitro were incubated with 10 μg/mL puromycin for 4 min, quickly
Table 3 List of PCR primers.
Gene Forward Reverse Organism
Acly Hs00982738_m1 (Thermo) mice
Gapdh Mm99999915_g1 (Thermo) mice
TBP CCACGGTGAATCTGTGCT GGAGTCGTCCTCGCTCTT fly
Elp1 TCGGCGGTTCCTTTCCAAAC GGTCCGATGCAACTTCAGATT fly
Elp3 AAGAAGTTGGGCGTGGGATT ATCCTTTTTGGCTTCGTGCG fly
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washed with warm PBS, and fixed for 10 min in 4% PFA-sucrose. After fixation and
permeabilization, the Duolink assay (DUO92007; DUO92004; DUO92002 Sigma)
was performed as recommended by the manufacturer using the following primary
antibodies: puromycin 1:75 (PMY-2A4 DSHB); Acly 1:100 (OAGA04026 Aviva
Systems Biology). Following puro-PLA, cells were post-fixed for 10 min in PFA-
sucrose, washed with PBS, blocked with 5% donkey serum in PBS, and labelled
with antitubulin antibody 1:1000 (ab6160) in Duolink Antibody Diluent (Sigma)
for 1 h. After incubation with fluorophore-labelled secondary antibody for 1 h and
further washes, cells were mounted with Fluorescence Mounting medium (S3023
Agilent Dako). Images were acquired with a Zeiss LSM-880 microscope using × 40
oil objective. Images were processed with ImageJ (NIH).
Cycloheximide pulse-chase assay. Primary fibroblasts from FD patients or
healthy controls were cultured in 6-well plates at 80% confluency before treatment
with 50 μg/mL cycloheximide (CHX) (C7698 Sigma) for 0 h, 4 h, 6 h, 8 h. All
samples were harvested simultaneously by washing the cells in each well with ice-
cold PBS, adding in each well 150 μL cell lysis buffer (50 mM Tris-HCl, pH 8,
containing 150 mM NaCl, 1% NP-40 supplemented with complete proteinase
inhibitor cocktail (Roche)) and subsequent mechanical scraping. Following incu-
bation on ice for 30 min, samples were centrifuged for 20 min at 13,000 x g to
collect the supernatant. Protein concentration of each sample was measured by
using the Protein Assay Kit (Pierce Biotechnology, Rockford) according to the
manufacturer’s instructions. All samples were resuspended in SDS buffer before
WB analysis.
Co-immunoprecipitation analysis. Co-immunoprecipitation experiments were
performed in HEK293 cells (Merck Chemicals, Brussels). Pierce Crosslink
immunoprecipitation kit (#26147) was used following the manufacturer’s
instructions. For Elp3-FLAG and Myc-Acly analysis 4 μg of Myc (Cell signaling),
Flag (Sigma-Aldrich), or general mouse IgG (Millipore) were crosslinked using DSS
to protein A/G. For detection by WB of Elp3-Flag or Myc-Acly Elp3 (Jesper
Svejstrup) antibody and Acly (cell signaling) were used.
Statistics and Reproducibility. Every experiment was repeated independently at
least two times under single-blinded condition and statistical analyses were gen-
erated with GraphPad Prism Software 7.0. For statistical analysis, data normality
was assessed via D’Agostino-Pearson omnibus normality test or Shapiro–Wilk
normality test. Comparison between two groups with normally distributed samples
was performed with two-sided unpaired t test, while comparisons among more
than two groups with one-way or two-way analysis of variance (ANOVA) followed
by Sidak’s, Dunn’s or Dunnet’s post hoc test. If normality was not reached, Mann-
Whitney or Kruskal–Wallis test were performed, to compare between two groups
or among more than two groups, respectively.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The proteomic data generated in this study have been deposited in the
ProteomeXChange database and can be accessed via the CX accession number:
PXD021186. Proteomic data supporting the findings of this study are available within the
paper and its supplementary information files. Source data are provided with this paper.
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